Skip to content

Clinical trials

Completed Amyloidosis trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Completed Country / region: Sweden Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20101
20111
20132
20151
20162
20171
20192
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Alnylam Pharmaceuticals3
Ionis Pharmaceuticals, Inc.2
Boston University1
C.T. Development America, Inc.1
Intellia Therapeutics1
Janssen Research & Development, LLC1
Takeda1
Umeå University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis16
Amyloid Neuropathies, Familial8
Alzheimer Disease4
Polyneuropathies4
Cardiomyopathies3
Amyloidosis, Familial2
Amyloid Neuropathies1
Lymphoma1
Multiple Myeloma1
Peripheral Nervous System Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.